The Key Role of Hepcidin-25 in Anemia in Multiple Myeloma Patients with Renal Impairment

The Key Role of Hepcidin-25 in Anemia in Multiple Myeloma Patients with Renal Impairment

<i>Background and objectives:</i> Anemia is common in multiple myeloma (MM) and is caused by a complex pathomechanism, including impaired iron homeostasis. Our aim is to evaluate the biomarkers of iron turnover: serum soluble transferrin receptor (sTfR) and hepcidin-25 in patients at var...

Full description

Bibliographic Details
Main Authors: Małgorzata Banaszkiewicz, Jolanta Małyszko, Krzysztof Batko, Ewa Koc-Żórawska, Marcin Żórawski, Paulina Dumnicka, Artur Jurczyszyn, Karolina Woziwodzka, Aleksandra Maleszka, Marcin Krzanowski, Andrzej Kraśniak, Ryszard Drożdż, Katarzyna Krzanowska
Format: Article
Language:English
Published: MDPI AG 2022-03-01
Series:Medicina
Subjects:
multiple myeloma
soluble transferrin receptor
anemia
hepcidin 25
renal impairment
tumor microenvironment
Online Access:https://www.mdpi.com/1648-9144/58/3/417

Internet

https://www.mdpi.com/1648-9144/58/3/417

Similar Items